Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website


Repligen reported $270K in Interest Expense on Debt for its fiscal quarter ending in March of 2023.

Interest Expense On Debt Change
Agilent A:US USD 24M 1000K
BioMarin Pharmaceutical BMRN:US USD 3.7M 77K
Bristol-Myers Squibb BMY:US USD 288M 6M
Catalent CTLT:US USD 47M 15M
Charles River Laboratories CRL:US USD 34.38M 399K
Danaher DHR:US USD 68M 4M
Dentsply International XRAY:US USD 19M 0
General Electric GE:US USD 12M 2M
Henry Schein HSIC:US USD 14M 3M
IQVIA Holdings Inc IQV:US USD 141M 13M
Myriad Genetics MYGN:US USD 500K 400K
NanoString Technologies NSTG:US USD 1.89M 6K
Pacific Biosciences Of California PACB:US USD 3.63M 18K
Patterson Companies PDCO:US USD 9.73M 2.19M
Peregrine Pharmaceuticals PPHM:US USD 620K 83K
Pfizer PFE:US USD 318M 5M
Repligen RGEN:US USD 270K 0
Thermo Fisher Scientific TMO:US USD 300M 31M
Waters WAT:US USD 14.44M 545K
West Pharmaceutical Services WST:US USD 2.2M 500K